Share this article on:

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results

Clumeck, Nathan MD*; Molina, Jean-Michel MD; Henry, Keith MD; Gathe, Joseph MD§; Rockstroh, Jürgen K. MD; DeJesus, Edwin MD; Wei, Xuelian PhD#; White, Kirsten PhD#; Fordyce, Marshall W. MD#; Rhee, Martin S. MD#; Szwarcberg, Javier MD#

JAIDS Journal of Acquired Immune Deficiency Syndromes: March 1st, 2014 - Volume 65 - Issue 3 - p e121–e124
doi: 10.1097/QAI.0000000000000089
Letters to the Editor